Lewis Lipsitz
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease (NCT05422885) | Lewis Lipsitz | 2022-05-20 |
Track Lewis Lipsitz automatically
Every clearance here is in the API, with alerts when new ones post.